133453-54-0 2,2,6b,9,9,12a-Hexamethyl-10-(3,4,5-trihydroxy-6-methyl-tetrahydro-pyran-2-yloxy)-1,3,4,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14b-octadecahydro-2H-picene-4a-carboxylic acid 4a(2H)-picenecarboxylic acid, 10-[(6-deoxy-beta-D-glucopyranosyl)oxy]-1,3,4,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14b-octadecahydro-2,2,6b,9,9,12a-hexamethyl-, (4aS,6bR,10S,12aR)- 6-Deoxy-beta-D-glucopyranosyl-pyrocincholate InChI=1/C35H56O7/c1-19-26(36)27(37)28(38)29(41-19)42-25-12-14-34(7)23(32(25,4)5)11-13-33(6)21-10-15-35(30(39)40)17-16-31(2,3)18-22(35)20(21)8-9-24(33)34/h19,22-29,36-38H,8-18H2,1-7H3,(H,39,40)/t19-,22?,23?,24?,25+,26-,27+,28-,29+,33+,34+,35-/m1/s Inermiside II rel-(4aR,6bS,10R,12aS)-2,2,6b,9,9,12a-hexamethyl-10-{[(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-1,3,4,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14b-octadecahydropicene-4a(2H